It had revealed that activation of the cGMP/PKG pathway plays an anticancer effect in melanoma [48], head and neck squamous cell carcinoma [49], and breast [50] and colon cancer [51]. This evidence concerns the gene PRKG1 and head and neck squamous cell carcinoma.